Market Tracker

05/24 7:40am ET

PDL BioPharma Inc (NASDAQ:PDLI)

3.15
Delayed Data
As of May 23
 -0.02 / -0.63%
Today’s Change
2.58
Today|||52-Week Range
6.83
-11.02%
Year-to-Date

Today’s Trading

Previous close3.17
Today’s open3.16
Day’s range3.15 - 3.23
Volume823,299
Average volume (3 months)2,154,450
Market cap$523.4M
Dividend yield6.35%
Data as of 05/23/2016

Growth & Valuation

Earnings growth (last year)+9.14%
Earnings growth (this year)-77.92%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+0.66%
P/E ratio1.7
Price/Sales0.99
Price/Book0.75

Competitors

 Today’s
change
Today’s
% change
RVNCRevance Therapeutics...-0.56-3.05%
SCMPSucampo Pharmaceutic...-0.04-0.35%
XNCRXencor Inc+0.07+0.54%
LOXOLoxo Oncology Inc+0.68+2.68%
Data as of 05/23/2016

Financials

Next reporting dateJuly 27, 2016
EPS forecast (this quarter)$0.08
Annual revenue (last year)$585.1M
Annual profit (last year)$332.8M
Net profit margin56.88%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Peter McLaughlin
Chief Financial Officer &
Vice President
Peter S. Garcia
Corporate headquarters
Incline Village, Nevada

Forecasts